Arrowhead Pharmaceuticals, Inc.
MX ˙ BMV ˙ US04280A1007
SecurityMX:ARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership7,934 shares
Latest Disclosed Value $ 497,461
Crossmark Global Holdings, Inc. reports 4.96% decrease in ownership of ARWR / Arrowhead Pharmaceuticals, Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 7,934 shares of Arrowhead Pharmaceuticals, Inc. (MX:ARWR) valued at $497,461 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 8,348 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of -4.96% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 7,934 -414 -4.96 497 -10.29 0.0073
2026-02-03 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 8,348 1,008 13.73 554 118.97 0.0079
2025-11-12 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 7,340 7,340 253 0.0038
2024-11-04 2024-09-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 0 -7,828 -100.00 0 0.0000
2024-07-29 2024-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 7,828 -523 -6.26 0 0.0039
2024-05-13 2024-03-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 8,351 1,106 15.27 0 0.0046
2024-02-13 2023-12-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 7,245 -572 -7.32 0 0.0046
2023-11-08 2023-09-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 7,817 -1,960 -20.05 0 0.0045
2023-07-31 2023-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 9,777 -375 -3.69 0 0.0074
2023-05-12 2023-03-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,152 -349 -3.32 0 0.0061
2023-01-19 2022-12-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,501 -307 -2.84 0 -100.00 0.0106
2022-11-01 2022-09-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,808 -154 -1.40 357 -7.51 0.0099
2022-07-29 2022-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,962 -430 -3.77 386 -26.34 0.0100
2022-05-11 2022-03-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 11,392 320 2.89 524 -28.61 0.0117
2022-01-10 2021-12-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 11,072 700 6.75 734 13.27 0.0159
2021-10-21 2021-09-30 13F/A-1 ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,372 -188 -1.78 648 -25.94 0.0152
2021-07-21 2021-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,560 -250 -2.31 875 22.04 0.0206
2021-04-15 2021-03-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,810 -120 -1.10 717 -14.54 0.0178
2021-01-14 2020-12-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 10,930 -1,680 -13.32 839 54.51 0.0212
2020-10-08 2020-09-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 12,610 40 0.32 543 0.00 0.0152
2020-08-14 2020-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 12,570 460 3.80 543 56.03 0.0158
2020-04-28 2020-03-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 12,110 -90 -0.74 348 -55.04 0.0125
2020-02-06 2019-12-31 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 12,200 -2,430 -16.61 774 87.86 0.0213
2019-10-09 2019-09-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 14,630 30 0.21 412 6.46 0.0120
2019-07-09 2019-06-30 13F ARROWHEAD PHARMACEUTICALS ICN COM 04280A100 14,600 14,600 387 0.0109
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.